Advertisement
Organisation › Details
Bay City Capital GF Xinde International Life Sciences Fund
Bay City Capital GF Xinde is a cross-border life sciences venture capital fund with a global diversified strategy ranging from seed stage to public companies, and including innovation, restructuring opportunities, and growth investing. To learn more, visit www.baycitycapital.com or www.gf.com.cn. *
Start | 2018-01-04 existent | |
Group | Bay City Capital LLC | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Region | San Francisco, CA | |
Country | United States (USA) | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne. | ||
Record changed: 2021-05-24 |
Advertisement
More documents for Bay City Capital LLC
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top